Current Affair 1:

News:

Just learn, why this forum?

To elevate India's position in the global pharmaceutical sector, the Indian Pharmacopoeia Commission (IPC), in collaboration with the Ministry of Health & Family Welfare and the Ministry of External Affairs, hosted an international delegation of policymakers and drug regulators from 15 countries.

The forum featured the launch of innovative digital platforms for pharmacopoeia and drug safety monitoring.

Who all participated?

The forum witnessed participation from various countries including Burkina Faso, Equatorial Guinea, Ghana, Guyana, Jamaica, Lao PDR, Lebanon, Malawi, Mozambique, Nauru, Nicaragua, Sri Lanka, Syria, Uganda and Zambia.

The forum aims to foster meaningful discussions on the recognition of the IP and the implementation of India’s flagship Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), popularly known as the Janaushadhi Scheme.

Two major initiatives of this forum:

A key highlight of the event was the launch of two significant digital platforms by the Hon’ble Minister of Health and Family Welfare and Chemicals & Fertilizers —

The IP Online Portal:

The IP Online Portal represents a major step towards digitalizing the Indian Pharmacopoeia, making drug standards more accessible to stakeholders worldwide. This initiative aligns with the Government of India's commitment to promoting environmentally friendly solutions under the ‘Digital India’ campaign.

Adverse Drug Reaction Monitoring System (ADRMS) software:

The ADRMS software is India’s first indigenous medical product safety database tailored to the needs of the Indian population. It facilitates the collection and analysis of adverse events related to medicines and medical devices, thereby significantly strengthening the country’s pharmacovigilance infrastructure.

<< Previous Next >>